105 related articles for article (PubMed ID: 23110993)
1. Access to regulatory data from the European Medicines Agency: the times they are a-changing.
Wieseler B; McGauran N; Kerekes MF; Kaiser T
Syst Rev; 2012 Oct; 1():50. PubMed ID: 23110993
[TBL] [Abstract][Full Text] [Related]
2. Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation.
Hopkins AM; Modi ND; Rockhold FW; Hoffmann T; Menz BD; Veroniki AA; McKinnon RA; Rowland A; Swain SM; Ross JS; Sorich MJ
J Clin Epidemiol; 2024 Mar; 167():111263. PubMed ID: 38219810
[TBL] [Abstract][Full Text] [Related]
3. The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors.
Hodkinson A; Dietz KC; Lefebvre C; Golder S; Jones M; Doshi P; Heneghan C; Jefferson T; Boutron I; Stewart L
Syst Rev; 2018 Aug; 7(1):117. PubMed ID: 30089508
[TBL] [Abstract][Full Text] [Related]
4. Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients.
Rohner E; Grabik M; Tonia T; Jüni P; Pétavy F; Pignatti F; Bohlius J
PLoS One; 2017; 12(12):e0189309. PubMed ID: 29228059
[TBL] [Abstract][Full Text] [Related]
5. Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status.
Boesen K; Gøtzsche PC; Ioannidis JPA
Epidemiol Psychiatr Sci; 2024 Mar; 33():e17. PubMed ID: 38529624
[TBL] [Abstract][Full Text] [Related]
6. Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.
Strech D; Littmann J
Trials; 2012 Jul; 13():100. PubMed ID: 22747684
[TBL] [Abstract][Full Text] [Related]
7. A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan.
Wolter KD; Kamatani A; Suzuki Y; Imaeda T; Dagher R; Safferman A; Junor R
Pharmaceut Med; 2024 May; 38(3):217-224. PubMed ID: 38555545
[TBL] [Abstract][Full Text] [Related]
8. Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports.
Jefferson T; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Onakpoya I; Heneghan CJ
BMJ Open; 2014 Sep; 4(9):e005253. PubMed ID: 25270852
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Koole SN; Huisman AH; Timmers L; Westgeest HM; van Breugel E; Sonke GS; van Waalwijk van Doorn-Khosrovani SB
Lancet Oncol; 2024 Mar; 25(3):e126-e135. PubMed ID: 38423058
[TBL] [Abstract][Full Text] [Related]
10. Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency.
Hamilton S; Bernstein AB; Blakey G; Fagan V; Farrow T; Jordan D; Seiler W; Shannon A; Gertel A;
Res Integr Peer Rev; 2016; 1():4. PubMed ID: 29451540
[TBL] [Abstract][Full Text] [Related]
11. Critical review of the TransCelerate Template for clinical study reports (CSRs) and publication of Version 2 of the CORE Reference (
Hamilton S; Bernstein AB; Blakey G; Fagan V; Farrow T; Jordan D; Seiler W; Gertel A;
Res Integr Peer Rev; 2019; 4():16. PubMed ID: 31406582
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications.
Argotti U; Leyens L; Lisbona C; López P; Alonso-Orgaz S; Nevado A; Cozzi V
Ther Innov Regul Sci; 2023 Nov; 57(6):1287-1297. PubMed ID: 37682461
[TBL] [Abstract][Full Text] [Related]
13. Production and citation of cochrane systematic reviews: a bibliometrics analysis.
Shen J; Li Y; Clarke M; Du L; Wang L; Zhong D
J Evid Based Med; 2014 May; ():. PubMed ID: 25156081
[TBL] [Abstract][Full Text] [Related]
14. The method quality of cross-over studies involved in Cochrane Systematic Reviews.
Ding H; Hu GL; Zheng XY; Chen Q; Threapleton DE; Zhou ZH
PLoS One; 2015; 10(4):e0120519. PubMed ID: 25867772
[TBL] [Abstract][Full Text] [Related]
15. EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers.
Sudlow R; Branson J; Friede T; Morgan D; Whately-Smith C
BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):73. PubMed ID: 27410386
[TBL] [Abstract][Full Text] [Related]
16. Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
Boskovic A; Møllebæk M; Kaae S
Ther Innov Regul Sci; 2019 Sep; ():2168479019871041. PubMed ID: 31510799
[TBL] [Abstract][Full Text] [Related]
17. A full-document analysis of the semantic relation between European Public Assessment Reports and EMA guidelines using a BERT language model.
Bergman E; Pasmooij AMG; Mol PGM; Westman G
PLoS One; 2023; 18(12):e0294560. PubMed ID: 38100432
[TBL] [Abstract][Full Text] [Related]
18. Experiences and challenges with the new European Clinical Trials Regulation.
Patrick-Brown TDJH; Bourner J; Kali S; Trøseid M; Yazdanpanah Y; Olliaro P; Olsen IC
Trials; 2024 Jan; 25(1):3. PubMed ID: 38167484
[TBL] [Abstract][Full Text] [Related]
19. Report of the European Medicines Agency Conference on RNA-Based Medicines.
Ehmann F; Kuhn A; Pasmooij AMG; Humphreys A; Van Hengel A; Dooley B; Anliker B; Svensson C; Capaldi D; Henshall D; Cooke E; Zhou H; Bastaerts H; Smink J; Van Gerven J; Enes L; Nechev L; Hoefnagel M; Driessens M; Wenger M; Blanquie O; Widomski P; Herold R; Thürmer R; Ruiz S; Thirstrup S; Goody S; Zaks T; Cordò V; Aartsma-Rus AM
Nucleic Acid Ther; 2024 Feb; 34(1):4-11. PubMed ID: 38174996
[TBL] [Abstract][Full Text] [Related]
20. Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.
Bartlett JA; Brewster M; Brown P; Cabral-Lilly D; Cruz CN; David R; Eickhoff WM; Haubenreisser S; Jacobs A; Malinoski F; Morefield E; Nalubola R; Prud'homme RK; Sadrieh N; Sayes CM; Shahbazian H; Subbarao N; Tamarkin L; Tyner K; Uppoor R; Whittaker-Caulk M; Zamboni W
AAPS J; 2015 Jan; 17(1):44-64. PubMed ID: 25421459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
